ITHACA, N.Y. — Rheonix, Inc., a developer of fully automated molecular testing solutions, will be presenting at the inaugural BTIG Emerging Technologies in Healthcare Diagnostics symposium. Richard Montagna, Ph.D., senior vice president for Scientific and Clinical Affairs at Rheonix, will speak about genomic workflow innovation and discuss the company’s breakthrough innovation utilizing a proprietary liquid-liquid extraction methodology for automated preparation of paraffin-preserved tissue samples for nucleic acid analysis.
Dr. Montagna’s comments… Read More »
BUFFALO, N.Y.— The University at Buffalo’s New York State Center of Excellence in Bioinformatics & Life Sciences (CBLS) will host Rheonix, Inc., a molecular diagnostic company based in Ithaca, N.Y., to deliver September’s Life Sciences Commercialization Lecture.
The lecture will take place on Sept. 18 from 4 to 5 p.m. in the Bruce A. Holm Commons area (2nd floor), at the CBLS, 701 Ellicott Street, Buffalo.
Senior Vice President for Scientific and… Read More »
ITHACA, N.Y. — Rheonix, Inc., a developer of fully automated molecular testing solutions, recently spoke at Beijing University of Chemical Technology, School of Information and Technology. Dr. Zongyuan Chen, senior research engineer at Rheonix, lectured on the in vitro diagnostics (IVD) market to an audience of 70 graduate students and faculty members and provided an in-depth look at Rheonix’s breakthrough platform, the EncompassMDx™. According to IVD Technology magazine, the U.S.… Read More »